620 likes | 745 Views
Abstract. Risk of CV disease increased 2-4 fold in DM ptTraditional risk factors can't completely explainedNon-diabetic studies demonstrated elevated Lp(a) and risk of atherosclerotic disordersRole of lipoprotein(a) in DM CV disease ?. Controversial questions. Plasma Lp(a) levels and phenotype
E N D
1. The Relationship Between Lipoprotein(a) and the Complications of Diabetes MellitusM.L Koschinsky. S.M. Marcovina. Acta Diabetol (2003) 40:65-76 ??????
????????
?????
2. Abstract Risk of CV disease increased 2-4 fold in DM pt
Traditional risk factors can’t completely explained
Non-diabetic studies demonstrated elevated Lp(a) and risk of atherosclerotic disorders
Role of lipoprotein(a) in DM CV disease ?
3. Controversial questions Plasma Lp(a) levels and phenotype distributions altered in type 1 and type 2 DM ?
Does the degree of metabolic control influence Lp(a) levels in these pt?
What is the relationship between Lp(a) and renal disease?
Do increased Lp(a) conc in DM pt contribute to the vascular complications?
Can the atherogenicity of Lp(a) in DM be enhanced in the absence of elevated levels of this lipoprotein due to bochemical modifications?
4. Introduction DM pt have 2-4 fold increased risk of developing CV disease
Traditional risk factors-hypertension, dyslipidemias-can’t completely account for the increase burden of CV disease
Level of metabolic control also does not appear to be a major contributing factor